Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Product Categories
(Total 12 Products for Brigatinib Cas 1197953 54 0)
Anti-cancer API Brigatinib cas 1197953-54-0
Brigatinib potently inhibits the in vitro kinase activity of ALK (IC50, 0.6 nM) and all five mutant variants tested, including G1202R (IC50, 0.6-6.6 nM). Brigatinib demonstrates a high degree of selectivity, only inhibiting 11 additional native or mutant kinases with IC50 <10 nM. These include ROS1, FLT3, and...
Anti-cancer API Brigatinib cas 1197953-54-0
Brigatinib potently inhibits the in vitro kinase activity of ALK (IC50, 0.6 nM) and all five mutant variants tested, including G1202R (IC50, 0.6-6.6 nM). Brigatinib demonstrates a high degree of selectivity, only inhibiting 11 additional native or mutant kinases with IC50 <10 nM. These include ROS1, FLT3, and...
Brigatinib CAS:CAS:1197953-54-0 Purity:99% Brigatinib AP26113 (Brigatinib) Brigatinib, AP26113
CAS No. 1197953-54-0 Brigatinib
Product Details Name:Brigatinib ,AP26113 Cas No.1197953-54-0 M.F:C29H39ClN7O2P M.W:584.09 Appearance:Off-white Powder Purity:99.0%+
cas:1197953-54-0 Brigatinib AP26113
Brigatinib 1197953-54-0 Brigatinib AP26113 (Brigatinib) Brigatinib, AP26113 5-Chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine...
Lapatinib Intermediate high quality CAS 23127-20-9
Lapatinib intermediates N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-iodoquinazolin-4-amine cas 231278-20-9 We supply high purity Lapatinib Intermediates, which should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. Introduction of CAS 231278-20-9
API Nilotinib powder with best price CAS 641571-10-0
GPM factory API Nilotinib with best price CAS 641571-10-0 We can supply Nilotinib Intermediates. Nilotinib is used for treating certain types of leukemia (eg, chronic myelogenous leukemia). API Nilotinib CAS 641571-10-0 Specification: 98% CAS NO.:641571-10-0 Appearance: white powder Molecular weight: 529.52 Molecular...
High Purity Nilotinib Intermediates cas 641569-94-0
Nilotinib intermediates 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid cas 641569-94-0 We supply Nilotinib Intermediates. Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous...
Lorlatinib (PF-6463922) intermediate 99% CAS 1454848-00-0
Lorlatinib (PF-06463922) intermediates 99% CAS 1454848-00-0 Name: methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate CAS: 1454848-00-0
Low price Dasatinib Impurity CAS 302964-24-5
Dasatinib Impurity 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302964-24-5 Product Name: Dasatinib Intermediate; 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide Form: White Powder Purity: 99%
CAS 950596-58-4 2-Amino-4 5-bis(2-methoxyethoxy)benzonitrile
High purity 2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile CAS no. 950596-58-4 Product Name: 2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile; Erlotinib Impurity 21 MF: C13H18N2O4 MW: 266.29 CAS No.: 950596-58-4 Form: White Powder Purity: 99% Shelf life: 2 years Storage: Keep seal in a dry and cool place COA: available
High quality Erlotinib Intermediate CAS 179688-29-0
Erlotinib Intermediate 6,7-Bis(2-methoxyethoxy)quinazolin-4-(3H)-one CAS 179688-29-0 Product Name: 6,7-Bis(2-methoxyethoxy)quinazolin-4-(3H)-one; 6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4(1H)-ONE MF: C13H16N2O6
Categories
High Quality Products
Send Us a Message
We didn't put all products on website. If you can't find the product you're looking for, please contact us for more information.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.